Sean Doherty is the Chairman of the JDRF T1D Fund — a venture philanthropy fund aimed at creating a market in type 1 diabetes (T1D)  by using capital and expertise to convince venture capital, biotech and pharma to make the investments needed to cure T1D.
In 2015, there was virtually no private investment in T1D; there was a gap between scientific advancements and the delivery of solutions to the people who need them.
Today, the JDRF T1D Fund is one of the largest disease-focused venture philanthropy funds in the world, with $175m in assets and their philanthropic dollars are spurring private investment to ultimately secure the billions needed to generate cures.
This episode showcases venture philanthropy and impact investment; it provides an overview of the funding and technologies being focused to tackle type 1 diabetes; and provides much insight on how philanthropy can catalyse private investment.
Thank you for downloading this episode of the Do One Better Podcast. Visit our Knowledge Hub at Lidji.org for information on 200+ case studies and interviews with remarkable leaders in philanthropy, sustainability and social entrepreneurship.